• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday

    10/19/22 4:18:19 AM ET
    $AKUS
    $AMZN
    $AVEO
    $CCL
    Specialty Chemicals
    Consumer Discretionary
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AKUS alert in real time by email

    U.S. stocks closed higher on Monday, with the Dow Jones gaining more than 300 points. Here is the list of some big stocks recording gains in the previous session.

    • Akouos, Inc. (NASDAQ:AKUS) shares surged 88.2% to close at $13.19 on Tuesday. Eli Lilly And Co (NYSE:LLY) agreed to acquire Akouos for a 78% premium over Monday’s closing price of $7.01.
    • AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) gained 42.4% to close at $14.92 after LG Chem announced it will acquire AVEO Oncology for $15 per share in cash.
    • Novonix Limited (NASDAQ:NVX) rose 20.4% to close at $5.61.
    • IAMGOLD Corporation (NYSE:IAG) rose 19.8% to close at $1.27 after the company announced an agreement to sell its interest in Rosebel Gold Mines to Zijin Mining for cash consideration of $360 million.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) rose 16% to close at $4.87.
    • Waldencast plc (NASDAQ:WALD) rose 15.4% to close at $9.69.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) gained 14.7% to close at $21.90.
    • Legend Biotech Corporation (NASDAQ:LEGN) surged 14.2% to settle at $45.91.
    • Tango Therapeutics, Inc. (NASDAQ:TNGX) rose 12.8% to close at $6.78.
    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) climbed 12.3% to settle at $32.78.
    • Seer, Inc. (NASDAQ:SEER) gained 11.3% to close at $6.98.
    • Carnival Corporation (NYSE:CCL) rose 11.1% to close at $8.08 amid strength in cruise stocks. The company earlier announced a private offering of $1.25 billion aggregate principal amount of Senior Priority Notes due 2028.
    • Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) rose 8.5% to close at $14.31.
    • Amazon.com, Inc. (NASDAQ:AMZN) gained 2.3% to close at $116.36. Amazon Web Services (AWS), an Amazon.com company, is planning to open an infrastructure Region in Thailand.
    Get the next $AKUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKUS
    $AMZN
    $AVEO
    $CCL

    CompanyDatePrice TargetRatingAnalyst
    Eli Lilly and Company
    $LLY
    2/20/2026$1350.00Overweight
    Barclays
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Legend Biotech Corporation
    $LEGN
    2/12/2026$24.00Buy → Neutral
    Rothschild & Co Redburn
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    Amazon.com Inc.
    $AMZN
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    Amazon.com Inc.
    $AMZN
    1/28/2026$305.00 → $315.00Outperform
    Oppenheimer
    More analyst ratings

    $AKUS
    $AMZN
    $AVEO
    $CCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief People Officer Dozier Eric gifted 481 shares, decreasing direct ownership by 3% to 14,455 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    2/19/26 4:18:48 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PRESIDENT & CFO Horn David R. sold $15,447 worth of shares (7,743 units at $1.99), decreasing direct ownership by 2% to 501,262 units (SEC Form 4)

    4 - Seer, Inc. (0001726445) (Issuer)

    2/19/26 4:11:51 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    CEO AND CHAIR Farokhzad Omid sold $48,646 worth of shares (24,385 units at $1.99), decreasing direct ownership by 0.72% to 3,349,064 units (SEC Form 4)

    4 - Seer, Inc. (0001726445) (Issuer)

    2/19/26 4:06:45 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AKUS
    $AMZN
    $AVEO
    $CCL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 7, 2024 - FDA Roundup: May 7, 2024

    For Immediate Release: May 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the treatment of post-traumatic stress disorder. The committ

    5/7/24 4:10:24 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $AMZN
    $AVEO
    $CCL
    SEC Filings

    View All

    Amendment: SEC Form S-4/A filed by Carnival Corporation

    S-4/A - CARNIVAL CORP (0000815097) (Filer)

    2/20/26 4:05:51 PM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    SEC Form SCHEDULE 13D filed by Seer Inc.

    SCHEDULE 13D - Seer, Inc. (0001726445) (Subject)

    2/20/26 10:54:03 AM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 6-K filed by NOVONIX Limited

    6-K - NOVONIX Ltd (0001859795) (Filer)

    2/18/26 3:27:47 PM ET
    $NVX
    Industrial Machinery/Components
    Miscellaneous

    $AKUS
    $AMZN
    $AVEO
    $CCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Eli Lilly with a new price target

    Barclays initiated coverage of Eli Lilly with a rating of Overweight and set a new price target of $1,350.00

    2/20/26 8:24:27 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Norwegian Cruise Line downgraded by Analyst with a new price target

    Analyst downgraded Norwegian Cruise Line from Overweight to Neutral and set a new price target of $20.00

    2/13/26 8:29:21 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Legend Biotech downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Legend Biotech from Buy to Neutral and set a new price target of $24.00

    2/12/26 7:23:25 AM ET
    $LEGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $AMZN
    $AVEO
    $CCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Vessel Ops & NO Dahlgren Patrik bought $99,578 worth of shares (5,550 units at $17.94), increasing direct ownership by 4% to 144,817 units (SEC Form 4)

    4 - Norwegian Cruise Line Holdings Ltd. (0001513761) (Issuer)

    11/25/25 4:15:09 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Director Curtis Harry C bought $96,250 worth of shares (5,000 units at $19.25), increasing direct ownership by 11% to 50,325 units (SEC Form 4)

    4 - Norwegian Cruise Line Holdings Ltd. (0001513761) (Issuer)

    11/12/25 8:30:11 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Director David Stella bought $129,870 worth of shares (6,986 units at $18.59), increasing direct ownership by 7% to 103,474 units (SEC Form 4)

    4 - Norwegian Cruise Line Holdings Ltd. (0001513761) (Issuer)

    11/10/25 8:00:57 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $AKUS
    $AMZN
    $AVEO
    $CCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Princess Cruises Celebrates National Margarita Day by Breaking The GUINNESS WORLD RECORDS™ Title for Most Margaritas Sold in 8 Hours

    Princess Cruises also Marks the Sale of Over 1 Million Signature 24K Margaritas Made with Award-Winning Pantalones Organic TequilaCOZUMEL, Mexico, Feb. 22, 2026 /PRNewswire/ -- Princess Cruises raised a salted-rim glass to National Margarita Day in record-breaking style, breaking a new GUINNESS WORLD RECORDS™ title for the Most Margaritas Sold in 8 Hours. The celebration aboard Regal Princess sold 3,410 handcrafted 24K Margaritas featuring Pantalones Organic Blanco Tequila, surpassing the previously held record of 2,728. The record-setting event took place on February 17, while

    2/22/26 10:00:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight

    The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming years, supported by rising prevalence. Additionally, the launch of emerging therapies such as RINVOQ (AbbVie), Bempikibart (Q32 Bio), Coacillium (Legacy Healthcare), ALM 223 (Almirall), Amlitelimab (Sanofi), HCW9302 (HCW Biologics), ALY-101 (ALYS Pharmaceuticals), DR-01 (Dren Bio), Rezpegaldesleukin (Nektar Therapeutics), and others will further propel the market growth.LAS VEGAS, Feb. 19, 2026 /PRNewswire/ -- Recently published Alopecia Areata Market Insights report includes a comprehensive understanding of current treatment practices, alopecia ar

    2/19/26 5:31:00 PM ET
    $ABBV
    $HCWB
    $INCY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Commercial Physical & Biological Resarch

    Patients with Crohn's disease maintained steroid-free remission for three years with Lilly's Omvoh (mirikizumab-mrkz)

    Landmark VIVID-2 data showed more than 90% of patients who achieved steroid-free remission at one year maintained steroid-free control through three years  Additional new data revealed exceptionally low surgery and hospitalization rates in Omvoh-treated patients across both Crohn's disease and ulcerative colitis (UC), underscoring its potential to fundamentally change disease trajectory Omvoh now stands alone as the only IL-23p19 inhibitor to show strong and durable efficacy with simple, consistent monthly dosing over four years in UC and three years in Crohn's diseaseINDIANAPOLIS, Feb. 19, 2026 /PRNewswire/ -- New long-term data from Eli Lilly and Company (NYSE:LLY) showed Omvoh (mirikizuma

    2/19/26 12:15:00 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $AMZN
    $AVEO
    $CCL
    Leadership Updates

    Live Leadership Updates

    View All

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Lilly to acquire Orna Therapeutics to advance cell therapies

    Orna's in vivo CAR-T pipeline includes potential best-in-class programs to reset the immune system and address B cell-driven autoimmune diseases Acquisition provides a broad platform for long-term innovation in genetic medicine and in vivo cell engineering INDIANAPOLIS and WATERTOWN, Mass., Feb. 9, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient's own body to generate cell

    2/9/26 7:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $AMZN
    $AVEO
    $CCL
    Financials

    Live finance-specific insights

    View All

    Carnival Corporation & plc Announces Exchange Rate for Quarterly Dividend

    Dividend at an initial rate of $0.15 (U.S.) per share payable on February 27, 2026MIAMI, Feb. 18, 2026 /PRNewswire/ -- On December 19, 2025, Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK) announced a quarterly cash dividend of $0.15 (U.S.) per share. The dividend is payable on February 27, 2026, to shareholders of record on February 13, 2026. Holders of Carnival Corporation common stock or Carnival plc ADSs will receive the dividend payable in U.S. dollars. The dividend for Carnival plc ordinary shares will be payable in sterling unless shareholders elected to receive the dividend in U.S. dollars by February 13, 2026.Dividends payable in sterling will be converted from U.S. dollars at

    2/18/26 9:30:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences

    BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), today announced that it will report fourth quarter 2025 financial results on March 5, 2026, before the open of the U.S. financial markets. The company does not intend to hold a conference call. Additionally, Tango Therapeutics management is scheduled to participate in three upcoming investor conferences: TD Cowen 46th Annual Health Care Conference, Boston Corporate presentation on Wednesday, March 4 at 1:10-1:40 PM ETWebcast link here Barclays 28th Annual Global Healthcare Conference, Miami Hosting 1x1 meetings on Tuesday, March 10 2026 Leerink Partners Global Healthcare Conference, Miami Fireside chat

    2/18/26 7:00:00 AM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IAMGOLD Reports Fourth Quarter and Year-End 2025 Results

    All monetary amounts are expressed in U.S. dollars, unless otherwise indicated.Toronto, Ontario--(Newsfile Corp. - February 17, 2026) - IAMGOLD Corporation (NYSE:IAG) (TSX:IMG) ("IAMGOLD" or the "Company") today reported its financial and operating results for the fourth quarter and year ended December 31, 2025. Preliminary operating results for the fourth quarter and year ended 2025, alongside operating guidance estimates for 2026, were previously disclosed on January 19, 2026. "I would like to congratulate the teams across IAMGOLD for another year of strong and safe operating performance," said Renaud Adams, President and Chief Executive Officer of IAMGOLD. "The timing has been highly favo

    2/17/26 7:01:00 PM ET
    $IAG
    Precious Metals
    Basic Materials

    $AKUS
    $AMZN
    $AVEO
    $CCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Tango Therapeutics Inc.

    SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)

    11/20/24 4:24:26 PM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Legend Biotech Corporation

    SC 13G/A - Legend Biotech Corp (0001801198) (Subject)

    11/14/24 1:22:39 PM ET
    $LEGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Legend Biotech Corporation

    SC 13G/A - Legend Biotech Corp (0001801198) (Subject)

    11/12/24 10:32:10 AM ET
    $LEGN
    Biotechnology: Pharmaceutical Preparations
    Health Care